Ancora Advisors, LLC Pfizer Inc Transaction History

Ancora Advisors, LLC

$4.06 Billion
Q3 2024

A detailed history of Ancora Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ancora Advisors, LLC holds 247,701 shares of PFE stock, worth $6.53 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

247,701

Previous 242,546 2.13%

Holding current value

$6.53 Million

Previous $6.79 Million 5.63%

% of portfolio

0.18%

Previous 0.18%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $142,793 - $161,815	5,155 Added 2.13%	247,701 $7.17 Million
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $321,585 - $376,837	-12,731 Reduced 4.99%	242,546 $6.79 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $174,938 - $200,885	6,757 Added 2.72%	255,277 $7.08 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $1.78 Million - $2.31 Million	68,102 Added 37.75%	248,520 $7.15 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $217,506 - $254,242	-6,778 Reduced 3.62%	180,418 $5.98 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $92,394 - $106,898	2,558 Added 1.39%	187,196 $6.87 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $98,081 - $127,687	2,490 Added 1.37%	184,638 $7.53 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $701,817 - $916,145	16,810 Added 10.17%	182,148 $9.33 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $125,197 - $152,834	2,861 Added 1.76%	165,338 $7.24 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $673,056 - $798,034	-14,465 Reduced 8.17%	162,477 $8.52 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $83,173 - $103,062	-1,818 Reduced 1.02%	176,942 $9.16 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $245,631 - $304,368	-5,369 Reduced 2.92%	178,760 $6.48 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $31,857 - $47,223	-771 Reduced 0.42%	184,129 $10.9 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $164,379 - $211,158	4,188 Added 2.32%	184,900 $7.95 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $70,096 - $79,407	1,952 Added 1.09%	180,712 $7.08 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $404,525 - $456,223	12,079 Added 7.25%	178,760 $6.48 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $791,833 - $1.01 Million	23,658 Added 16.54%	166,681 $6.14 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $439,356 - $515,465	13,838 Added 10.71%	143,023 $5.25 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $384,270 - $466,177	-12,758 Reduced 8.99%	129,185 $4.22 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $362,066 - $517,314	-13,395 Reduced 8.62%	141,943 $4.63 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $7.63 Million - $8.66 Million	-231,672 Reduced 59.86%	155,338 $6.09 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $302,092 - $391,724	9,298 Added 2.46%	387,010 $13.9 Million
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $236,930 - $266,018	6,407 Added 1.73%	377,712 $16.4 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $448,162 - $492,381	11,951 Added 3.33%	371,305 $15.8 Million
Q4 2018 Feb 15, 2019	BUY	$38.47 - $43.86 $155,187 - $176,931	4,034 Added 1.14%	359,354 $15.7 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $2.22 Million - $2.7 Million	64,468 Added 22.17%	355,320 $15.7 Million
Q2 2018 Aug 10, 2018	BUY	$32.98 - $35.16 $45,908 - $48,942	1,392 Added 0.48%	290,852 $10.6 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $259,779 - $301,379	8,141 Added 2.89%	289,460 $10.3 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $533,357 - $565,910	16,036 Added 6.04%	281,319 $10.2 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $8.22 Million - $9.06 Million	265,283	265,283 $9.47 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Account

Ancora Advisors, LLC Pfizer Inc Transaction History